The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Progress in the development of enzyme-based nerve agent bioscavengers
Open accessAbstract
Acetylcholinesterase is the physiological target for acute toxicity of nerve agents. Attempts to protect acetylcholinesterase from phosphylation by nerve agents, is currently achieved by reversible inhibitors that transiently mask the enzyme active site. This approach either protects only peripheral acetylcholinesterase or may cause side effects. Thus, an alternative strategy consists in scavenging nerve agents in the bloodstream before they can reach acetylcholinesterase. Pre- or post-exposure administration of bioscavengers, enzymes that neutralize and detoxify organophosphorus molecules, is one of the major developments of new medical counter-measures. These enzymes act either as stoichiometric or catalytic bioscavengers. Human butyrylcholinesterase is the leading stoichiometric bioscavenger. Current efforts are devoted to its mass production with care to pharmacokinetic properties of the final product for extended lifetime. Development of specific reactivators of phosphylated butyrylcholinesterase, or variants with spontaneous reactivation activity is also envisioned for rapid in situ regeneration of the scavenger. Human paraoxonase 1 is the leading catalytic bioscavenger under development. Research efforts focus on improving its catalytic efficiency toward the most toxic isomers of nerve agents, by means of directed evolution-based strategies. Human prolidase appears to be another promising human enzyme. Other non-human efficient enzymes like bacterial phosphotriesterases or squid diisopropylfluorophosphatase are also considered though their intrinsic immunogenic properties remain challenging for use in humans. Encapsulation, PEGylation and other modifications are possible solutions to address this problem as well as that of their limited lifetime. Finally, gene therapy for in situ generation and delivery of bioscavengers is for the far future, but its proof of concept has been established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Masson, P., & Lockridge, O. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.12.005 · Cited by 233 · cited 1×
“More than 60 mutants of hBChE and hAChE were created by inserting a second nucleophile in the active center (for reviews see: [63,64]).”
Background
Cited by
Li, P., Moon, S.-Y., Guelta, M. A., Harvey, S. P., Hupp, J. T., & Farha, O. K. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b03673 · Cited by 365
Nanosizing a Metal–Organic Framework Enzyme Carrier for Accelerating Nerve Agent Hydrolysis
Li, P., Moon, S.-Y., Guelta, M. A., Lin, L., Gómez-Gualdrón, D. A., Snurr, R. Q., Harvey, S. P., Hupp, J. T., & Farha, O. K. (2016) · ACS Nano · doi:10.1021/acsnano.6b04996 · Cited by 266
Nerve Agents: What They Are, How They Work, How to Counter Them
Costanzi, S., Machado, J.-H., & Mitchell, M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00148 · Cited by 253
Metadata
- Authors
- Nachon, F., Brazzolotto, X., Trovaslet, M., & Masson, P.
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 206
- Issue
- 3
- Pages
- 536-544
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W1966830656
- Cited by
- 165
- References
- 1
- FWCI
- 13.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress in the development of enzyme-based nerve agent bioscavengers. https://app.cochat.ai/papers/10.1016/j.cbi.2013.06.012
- The paper
- Nachon, F., Brazzolotto, X., Trovaslet, M., & Masson, P. (2013). Progress in the development of enzyme-based nerve agent bioscavengers. Chemico-Biological Interactions. https://doi.org/10.1016/j.cbi.2013.06.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.